Status:
COMPLETED
Pharmacodynamics of Injection of Cisatracurium Base on Lean Body Mass Pattern to Maintain Deep Neuromuscular Blockade in Obese Patients
Lead Sponsor:
The First Hospital of Qinhuangdao
Conditions:
Obese Patients
Laparoscopic Colorectal Surgery
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
To observe the pharmacodynamics of intravenous injection of cisatracurium to maintain deep neuromuscular blockade in obese patients with lean body mass in laparoscopic colorectal surgery
Detailed Description
According to the random number table method, one hundred and twenty patients who underwent elective laparoscopic colorectal surgery were divided into four groups (n=30): Normal weight patients accordi...
Eligibility Criteria
Inclusion
- Laparoscopic Colorectal Surgery
- American Society of Anesthesiologists (ASA) grades I-III
Exclusion
- Patients with heart, lung and other vital organ disorders
- Preoperative fluid and electrolyte disturbance
- Preoperative water and electrolyte disorders have a history of neuromuscular disease or take medications that have an impact on neuromuscular function
- There is a significant airway difficulty
- Refuse to sign informed consent
Key Trial Info
Start Date :
March 16 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 3 2022
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05391958
Start Date
March 16 2021
End Date
July 3 2022
Last Update
January 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First hosptial of Qinhuangdao
Qinhuangdao, China